Sendai virus recombinant vaccine expressing hPIV-3 HN or F elicits protective immunity and combines with a second recombinant to prevent hPIV-1, hPIV-3 and RSV infections

The human parainfluenza viruses (hPIVs) and Respiratory Syncytial Virus (RSV) are the leading causes of serious respiratory illness in the human pediatric population. Despite decades of research, there are currently no licensed vaccines for either the hPIV or RSV pathogens. Here we describe the test...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Zhan, Xiaoyan, Slobod, Karen S., Krishnamurthy, Sateesh, Luque de Johnson, Laura E., Takimoto, Toru, Jones, Bart, Surman, Sherri, Russell, Charles, Portner, Allen, Hurwitz, Julia L.
פורמט: Artigo
שפה:Inglês
יצא לאור: 2008
נושאים:
Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC2728217/
https://ncbi.nlm.nih.gov/pubmed/18499307
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2008.04.022
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים